Inactivated poliovirus vaccine

Human Vaccines

Volumn 3, Issue 3, 2007, Pages 71-72

  Arya, Subhosh C ^a   Agarwal, Nirmala ^a  

^a SANT PARMANAND HOSPITAL   (India)

Author keywords

Adverse environment; Combined vaccine; Inactivated polio vaccine; Serologic response

Indexed keywords

INACTIVATED POLIOVIRUS VACCINE; LIVE VACCINE; MATERNAL ANTIBODY; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY TITER; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG POTENCY; DRUG STORAGE; GEOGRAPHY; HUMAN; IMMUNIZATION; LETTER; PREVALENCE; SEROCONVERSION;

EID: 34248233076     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.3.4057     Document Type: Letter

References (7)

1. Centers for Disease Control and Prevention. Recommended childhood and adolescents immunization schedules - United States, 2006. MMWR Morb Mortal Wkly Rep 2006; 54:Q1-Q4.
2. Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P, Boceta R, Romero A, Lopez G, Dal-Re R. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanusacellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116:1292-8.
3. Dayan GH, Thorley M, Yamamura Y, Rodriguez N, McLaughlin S, Torres LM, Seda A, Carbia M, Alexander LN, Caceres V, Pallansch MA. Serologic response to inactivated polio-virus vaccine: a randomized clinical trial comparing 2 vaccination schedule in Puerto Rico. J Infect Dis 2007; 195:12-20.
4. Sauerbrei A, Prager J, Bischoff A, Wutzler P. Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004; 47:10-5.
5. Agarwal SC, Bardoloi JN, Sehgal S, Gupta AN. Placental transmission of neutralizing antibodies to poliomyelitis virus. Indian J Med Res 1971; 59:1703-7.
6. Requirements for the production and control of poliomyelitis vaccine (inactivated). In: WHO Expert Committee on Biological Standardization Fifty-first report. Geneva. WHO Technical Report Series, vol 913: p 32-65 [Annex3].
7. Saraswathy TS, Sinniah M, Lee WS, Lee PC. The value of potency testing of poliomyelitis and measles vaccines as an integral part of cold chain surveillance. Southeast Asian J Trop Med Public Health. 1993; 24:265-8.